Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

NAVISTAR® THERMOCOOL® Catheter for the Radiofrequency Ablation of Symptomatic Paroxysmal Atrial Fibrillation- Treatment Use Study

NCT00721149 is registered in ClinicalTrials.gov with Biosense Webster, Inc. as lead sponsor.

NCT NCT00721149
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00721149 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
NAVISTAR® THERMOCOOL® Catheter for the Radiofrequency Ablation of Symptomatic Paroxysmal Atrial Fibrillation- Treatment Use Study
Lead sponsor
Biosense Webster, Inc.
Phase
Phase 3
Overall status
Terminated
Start date
September 30, 2008
Completion date
December 31, 2009
Enrollment
10 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

arrhythmia, atrial fibrillation, heart diseases